Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenal Artery Ablation for Primary Aldosteronism
NCT03653845Phase 3Unknown
- Sponsor
- Army Medical University
- Start
- Jul 2018
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in primary aldosteronism (PA) and hypertension (HTN) (2 arms), sponsored by Army Medical University. Primary endpoint: Change of 24-h average systolic blood pressure at 24 weeks. Status: unknown.
02
Conditions
primary aldosteronism (PA)hypertension (HTN)
Beyond the preview
Go deeper on NCT03653845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03653845.